CAFELKIBART
UNII YN4XWR5BUJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Cafelkibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YN4XWR5BUJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2851855-89-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YN4XWR5BUJ

CAS Registry Number

2851855-89-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CAFELKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C186374

National Cancer Institute reference terminology for clinical and research data.

INN ID

13048

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cafelkibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CAFELKIBART

Common Names & Synonyms

CAFELKIBART [INN]

H-GAMMA1 HEAVY CHAIN (1-453) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV10-1*02 (92.9%) -(IGHD) -IGHJ4*01 (93.8%) S123>L (118)/HOMO SAPIENS IGHV3-73*01 (88.0%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.10.14) (26-33.51-60.99-112)) (1-123) -HOMO SAPIENS IGHG1*01, G1M17,1 CH1 K120, CH3 D12, L14, G1V7 CH2 D3, E117 (CH1 K120 (220) (124-221), HINGE 1-15 (222-236), CH2 S3>D (245), I117>E (338) (237-346), CH3 D12 (362), L14 (364) (347-451), CHS (452-453)) (124-453)), (226-219')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-219') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV2-137*01 (91.0%) -IGKJ4*01 (91.7%) S120>Q (115')/HOMO SAPIENS IGKV2-28*01 (87.0%) -IGKJ2*02 (100%), CDR-IMGT (11.3.9) (27'-37'.55'-57'.94'-102')) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158'), V101 (196') (113'-219')); DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (245-ASPARTIC ACID,338-GLUTAMIC ACID), ANTI-(HUMAN CC CHEMOKINE RECEPTOR CCR8) (HUMAN-MUS MUSCULUS MONOCLONAL LM-108 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LM-108 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CCR8 (C-C MOTIF CHEMOKINE RECEPTOR 8, CKR-L1, CDW198))